tiprankstipranks
Pharvaris CBO Resigns, Team Absorbs Duties
PremiumCompany AnnouncementsPharvaris CBO Resigns, Team Absorbs Duties
2M ago
Pharvaris Refines License Terms with BRAIN Biotech
Premium
Company Announcements
Pharvaris Refines License Terms with BRAIN Biotech
2M ago
Pharvaris initiated with a Buy at JonesResearch
Premium
The Fly
Pharvaris initiated with a Buy at JonesResearch
2M ago
Pharvaris provides business update, expands deucrictibant development program
PremiumThe FlyPharvaris provides business update, expands deucrictibant development program
3M ago
Pharvaris Advances HAE Treatment Trials
Premium
Company Announcements
Pharvaris Advances HAE Treatment Trials
3M ago
Wedbush reveals three potential buyout targets for Biogen
Premium
The Fly
Wedbush reveals three potential buyout targets for Biogen
4M ago
Pharvaris Showcases Promising HAE Treatment Data
PremiumCompany AnnouncementsPharvaris Showcases Promising HAE Treatment Data
6M ago
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
Premium
The Fly
Pharvaris’ deucrictibant shows positive results in HAE attack prevention
6M ago
Pharvaris price target lowered to $31 from $35 at Wedbush
Premium
The Fly
Pharvaris price target lowered to $31 from $35 at Wedbush
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100